Clopidogrel 75 mg is a daily tablet that prevents blood clots by stopping platelets from sticking together. It’s one of the most commonly prescribed medications after a heart attack, stroke, or stent placement, and it’s sold under the brand name Plavix as well as several generic versions. The 75 mg dose is the standard daily maintenance dose most people take.
Why It’s Prescribed
Clopidogrel is prescribed to reduce the risk of future heart attacks and strokes in people who have already experienced one of these events or who have related cardiovascular conditions. Specifically, it’s approved for:
- Recent heart attack or stroke: to prevent a second event from occurring
- Acute coronary syndrome: including unstable chest pain and active heart attacks, usually alongside aspirin
- Peripheral arterial disease: poor blood flow in the legs caused by narrowed arteries
It’s also sometimes used off-label to prevent clots in people with atrial fibrillation, a condition where the heart beats irregularly. In many of these situations, clopidogrel is taken alongside a low dose of aspirin. This combination, called dual antiplatelet therapy, is standard after a heart attack or stent procedure.
How It Works
Your blood contains small cell fragments called platelets. When you get a cut, platelets clump together to form a clot and stop the bleeding. But inside damaged or narrowed arteries, that same clumping process can block blood flow and cause a heart attack or stroke.
Clopidogrel blocks a specific receptor on the surface of platelets called P2Y12. This receptor normally responds to chemical signals that tell platelets to activate and stick together. Once clopidogrel’s active form locks onto the receptor, it permanently disables it by breaking the receptor into smaller, nonfunctional pieces that can no longer receive those signals. Because this change is irreversible, each platelet affected by clopidogrel stays “off” for the rest of its lifespan, roughly 7 to 10 days.
Clopidogrel is a prodrug, meaning the tablet itself isn’t active. Your liver has to convert it into its working form before it can do anything. This conversion step is important because it means anything that interferes with liver enzymes can affect how well the drug works.
The 75 mg Dose vs. Loading Doses
The 75 mg tablet is the standard daily maintenance dose, taken once a day for as long as your doctor recommends. In emergency situations, though, doctors often start with a much larger “loading dose” of 300 mg or even 600 mg. This higher initial dose floods the system quickly, achieving stronger platelet inhibition within hours rather than days.
At the 75 mg maintenance dose, the antiplatelet effect is moderate. Research from the American Heart Association found that up to one third of patients on the 75 mg dose may still have higher-than-ideal platelet activity. This doesn’t mean the drug isn’t working, but it’s one reason doctors monitor patients closely after major cardiac events and sometimes adjust therapy.
How Long You’ll Take It
The duration depends on why you were prescribed it. After receiving a coronary stent, guidelines generally recommend dual antiplatelet therapy (clopidogrel plus aspirin) for at least one month with a bare metal stent and typically 6 to 12 months with a drug-eluting stent. Data from the DAPT trial showed that extending this combination beyond one year further reduced stent complications and heart attacks (2.1% vs. 4.1% with aspirin alone), though it came with a slightly higher bleeding rate (2.5% vs. 1.6%).
For people who’ve had a stroke or have peripheral arterial disease without a stent, clopidogrel is often prescribed long term, sometimes indefinitely. Your prescriber will weigh your personal risk of clotting against your risk of bleeding when deciding the right timeline.
Bleeding Risk and Side Effects
Because clopidogrel’s entire purpose is to reduce clotting, the most significant side effect is bleeding. You may bruise more easily, bleed longer from cuts, or notice bleeding gums when brushing your teeth. These minor effects are common and generally manageable.
Serious bleeding is less common but worth understanding. In a large clinical trial of over 45,000 patients taking clopidogrel with aspirin, major bleeding (defined as bleeding that required a transfusion or was life-threatening) occurred in about 0.6% of patients. Non-major bleeding, like nosebleeds or gastrointestinal bleeding that didn’t require hospitalization, occurred in roughly 3.6%. In another trial comparing clopidogrel alone to aspirin alone, gastrointestinal bleeding was actually slightly lower with clopidogrel (2% vs. 2.7%), and hospitalizations for bleeding were also lower (0.7% vs. 1.1%).
Other possible side effects include stomach pain, diarrhea, and headache, though most people tolerate the medication well.
The Omeprazole Interaction
One of the most important drug interactions involves certain heartburn medications called proton pump inhibitors, particularly omeprazole (Prilosec). Because clopidogrel relies on a specific liver enzyme to become active, drugs that block this enzyme can reduce clopidogrel’s effectiveness. The FDA has issued warnings about this combination. If you need a stomach acid reducer while on clopidogrel, your doctor may recommend an alternative that doesn’t interfere with the same enzyme.
Stopping Before Surgery
If you need elective surgery, clopidogrel typically needs to be stopped 5 days beforehand to allow your platelets to recover enough clotting ability for safe surgery. In urgent situations where waiting isn’t an option, a shorter pause of 3 days or less may be considered, though this increases bleeding risk during the procedure. You should never stop clopidogrel on your own without guidance, especially after a stent, because stopping too soon raises the risk of a clot forming inside the stent.
Genetic Variation and Response
Not everyone processes clopidogrel the same way. Because the drug depends on liver enzymes to become active, people with genetic variations in those enzymes may convert it poorly and get less protection. An estimated 2 to 14% of the population (depending on ethnicity) are “poor metabolizers.” Some doctors order genetic tests to check for this, particularly after a stent procedure, and may switch patients to a different antiplatelet medication if their metabolism suggests clopidogrel won’t work well enough.